Extended thromboprophylaxis with betrixaban in acutely ill medical patients

New England Journal of Medicine

Volumn 375, Issue 6, 2016, Pages 534-544

  Cohen, Alexander T ^a   Harrington, Robert A ^b   Goldhaber, Samuel Z ^d   Hull, Russell D ^f   Wiens, Brian L ^c   Gold, Alex ^c   Hernandez, Adrian F ^g   Gibson, C Michael ^e   Bello, F ^h   Ferrari, A E ^h   Jure, H ^h   Macin, S ^h   Oliva, M ^h   Parody, M ^h   Poy, C ^h   Baker, R ^h   Colquhoun, D ^h   Coughlin, P ^h   Finfer, S ^h   Rubinfeld, A ^h   Huber, K ^h   Konig J ^h   Mathies, R ^h   Pilger, E ^h   Schoenerr, H ^h   Adzerikho, I ^h   Koryk, V ^h   Mikhailova, E ^h   Mitkovskaya, N ^h   Pimanov, S ^h   Polonetsy, L ^h   Soroka, N ^h   Blockmans, D ^h   Delforge, M ^h   Dive, A ^h   Lienart, F ^h   Motte, S ^h   Bizzacchi, J ^h   Fiss, E ^h   Freire, A ^h   Manenti, E ^h   Ramacciotti, E ^h   Raymuno, S ^h   Rocha, A ^h   Saraiva, J F ^h   Dimov, B ^h   Grigorov, M ^h   Kalpachki, R ^h   Kamenova, Z ^h   Kostadinova, M ^h   Milanova, M ^h   Mincheva, V ^h   Pencheva, G ^h   Raev, D ^h   Runev, N ^h   Stoeva, N ^h   Stoyanov, M ^h   Syulemzova, S ^h   Todorov, G ^h   Tokmakova, M ^h   Dhar, A ^h   Douketis, J ^h   Kahn, S ^h   Le Gal, G ^h   Pearce, M ^h   Provencher, S ^h   Verreault, S ^h   Alarcon, M ^h   Canon C ^h   Lazcano, M ^h   Cardenas, S ^h   Butkovic Soldo, S ^h   Car, S ^h   Ciglenecki, N ^h   Francetic, I ^h   Jakopovic, M ^h   Kalinic Grgorinic, H ^h   Knezevic, A ^h   Malojcic, B ^h   Marusic, S ^h   Vagic, J ^h   Skerk, V ^h   Cermak, O ^h   Chlumsky, J ^h   Chochola, J ^h   Cizek, V ^h   Dunaj, M ^h   Dusek, J ^h   Francek, L ^h   Havelka, J ^h   Herold, M ^h   Holaj, R ^h   Horny, I ^h   Hubac, J ^h   Jajtner, P ^h   Kolman, P ^h   Lang, P ^h   Mayer, O ^h   Mikulova, J ^h   Podpera, I ^h   Reiterer, P ^h   Spacek, R ^h   Vejvoda, J ^h   Vyhnanek, M ^h   Christensen, H ^h   Lassen, M ^h   Storgaard, M ^h   Tuxen, C ^h   Urhammer, S ^h   Lember, M ^h   Marandi, T ^h   Uuetoa, T ^h   Airaksinen, J ^h   Honkaniemi, J ^h   Kaaja, R ^h   Lassila, R ^h   Saarinen, J ^h   Tatlisumak, T ^h   Vikman, S ^h   Agraou, B ^h   Aquilanti, S ^h   Belhassane, A ^h   Brisot, D ^h   De Geeter, G ^h   Debourdeau, P ^h   Decoulx, E ^h   El Kouri, D ^h   Falvo, N ^h   Grange, C ^h   Lacroix, P ^h   Messas, E ^h   Mismetti, P ^h   Montaclair, K ^h   Mottier, D ^h   Paleiron, N ^h   Payot, L ^h   Pernod, G ^h   Pottier, P ^h   Proust, A ^h   Quere, I ^h   Roy, P M ^h   Schmidt, J ^h   Simoneau, G ^h   Datikashvili David, I ^h   Khabeishvili, G ^h   Khintibidze, I ^h   Kobulia, B ^h   Megreladze, I ^h   Pagava, Z ^h   Paposhvili, K ^h   Shaburishvili, T ^h   Amann, B ^h   Berrouschot, J ^h   Beyer Westendorf, J ^h   Blessing, E ^h   Bott, M ^h   Dengler, T ^h   Dziewas, R ^h   Genth Zotz, S ^h   Hamann, F ^h   Horacek, T ^h   Klimpe, S ^h   Kroning R ^h   Lapp, H ^h   Lawall, H ^h   Licka, M ^h   Rizos, T ^h   Schellong, S ^h   Tiefenbacher, C ^h   Weimar, C ^h   Zeymer, U ^h   Alkonyi, B ^h   Falukozy J ^h   Futo, L ^h   Katona, A ^h   Kirschner, R ^h   Kristof P ^h   Lakatos, F ^h   Laszlo, Z ^h   Lupkovics, G ^h   Merkely, B ^h   Andras C ^h   Nemeth L ^h   Papp, A ^h   Soltesz, P ^h   Sudar Z ^h   Szabo, G ^h   Szegedi, N ^h   Timar G ^h   Valco J ^h   Vertes, A ^h   Efrati, S ^h   Elias, M ^h   Gafter, A ^h   Hayek, T ^h   Hussein, O ^h   Lishner, M ^h   Lugassy, G ^h   Zeltser, D ^h   Ageno, W ^h   Cerveri, I ^h   D'Angelo, A ^h   De Pellegrin, A ^h   Imberti, D ^h   Landolfi, R ^h   Lembo, G ^h   Lodigiani, C ^h   Moia, M ^h   Molteni, M ^h   Mumoli, N ^h   Novo, S ^h   Orlandini, F ^h   Parisi, R ^h   Pizzini, A ^h   Pomero, F ^h   Salvi, A ^h   Schenone, A ^h   Visona A ^h   Krievins, D ^h   Martinova, V ^h   Pontaga, N ^h   Rozitis, V ^h   Stukena, I ^h   Alekniene, B ^h   Bagdonas, A ^h   Basijokiene, V ^h   Butkiene, Z ^h   Griskeviciene, V ^h   Naudziunas, A ^h   Norvaisiene, R ^h   Norviliene, R ^h   Petrauskiene, R ^h   Poskiene, R ^h   Susinskiene, D ^h   Valavicius, A ^h   Leon, R ^h   Pereyra, R ^h   Karlo, L ^h   Horna, M ^h   Osores, J ^h   Salas, M ^h   Yanez L ^h   Fryze, W ^h   Gaciong, Z ^h   Gniot, J ^h   Gorecka, D ^h   Gruenpeter, P ^h   Grzelakowski, P ^h   Jastrzebski, D ^h   Kucharski, L ^h   Mirek Bryniarska, E ^h   Pulkowski, G ^h   Sobkowicz, B ^h   Sulik, P ^h   Tomkowski, W ^h   Walasek, L ^h   Waldemar, K ^h   Wrzesinski, K ^h   Balogh, Z E ^h   Bojinca, M ^h   Marin, I ^h   Mot, S ^h   Musetescu, R ^h   Podoleanu, C ^h   Popescu, M ^h   Stamate, S ^h   Stanciulescu, G ^h   Vida Simiti, L ^h   Abashev, A ^h   Andreev, D ^h   Apartsin, K ^h   Arkhipov, M ^h   Averkov, O ^h   Barbarash, O ^h   Belskaya, G ^h   Bogdanov, E ^h   Boldueva, S ^h   Chefranova, Z ^h   Dovgalevskiy, Y ^h   Ershova, O ^h   Goloshchekin, B ^h   Khachatryan, N ^h   Klein, G ^h   Kobalava, Z ^h   Kosmacheva, E ^h   Kostenko, V ^h   Malygin, A ^h   Martynenko, T ^h   Martynenko, V ^h   Maslova, N ^h   Mordovin, V ^h   Nikolaev, K ^h   Nilk, R ^h   Panchenko, E ^h   Popov, D ^h   Privalova, E ^h   Reshetko, O ^h   Sergeeva, E ^h   Shapovalova, Y ^h   Shpagina, L ^h   Shvarts, Y ^h   Simanenkov, V ^h   Solovyov, O ^h   Vishneva, E ^h   Vishnevskiy, A ^h   Apostolovic, S ^h   Celic, V ^h   Ilic, S ^h   Kovacevic Kuzmanovic, A ^h   Miloradovic, V ^h   Tan, R S ^h   Bodikova, S ^h   Cervenakova, A ^h   Dvorak, M ^h   Gaspar, L ^h   Herman, O ^h   Hrubon, A ^h   Kokles, M ^h   Krastev, G ^h   Payer, J ^h   Prokop, D ^h   Spisakova, M ^h   Adler, D ^h   Basson, M ^h   Breedt, J ^h   Engelbrecht, J ^h   Jacobson, B ^h   Mitha, I ^h   Van Dyk, C ^h   Sala, L A ^h   Lopez C ^h   Bisbe, J ^h   Guardiola, A ^h   Cepeda, J M ^h   Cereto, F ^h   Santos, E ^h   Ferrer, R ^h   Cerezo, J ^h   Gonzales Porras, J R ^h   Grandes, J ^h   Jimenez D ^h   Mellibovsky, L ^h   Richart, C ^h   Riera, A ^h   Trujillo, J ^h   Nunez, J A ^h   Villalta, J ^h   Akgul, O ^h   Guneri, S ^h   Kilichesmez, K ^h   Kirma C ^h   Kutluk, H ^h   Nazliel, B ^h   Okumus, G ^h   Ongen, G ^h   Tigen, K ^h   Topcuoglu, M ^h   Tuncay, E ^h   Abrahamovych, O ^h   Batushkin, V ^h   Brozhyk, J ^h   Burmak, I ^h   Godlevska, O ^h   Goloborodko, A ^h   Goloborodko, B ^h   Goncharova, Y ^h   Gryb, V ^h   Karpenko, O ^h   Kopytsya, M ^h   Koshlia, V ^h   Krakhmalova, O ^h   Kyrychenko, I ^h   Legkonogov, O ^h   Malynovsky, Y ^h   Maslovaskyi, V ^h   Nikonov, V ^h   Parkhomenko, O ^h   Perepeliuk, M ^h   Reshotko, D ^h   Rudenko, L ^h   Ryabichenko, T ^h   Svyridova, I ^h   Svyshchenko, Y ^h   Tseluyko, V ^h   Ursol, G ^h   Vakaliuk, I ^h   Vishnivestsky, I ^h   Voronkov, L ^h   Yagensky, A ^h   Body, R ^h   Davis, M ^h   MacCallum, P ^h   McCollum, C ^h   Natarajan, I ^h   Almasri, E ^h   Amin, M ^h   Anderson, C ^h   Baker, S ^h   Barney, J ^h   Bastani, A ^h   Bercz, P ^h   Bidair, M ^h   Carman, T ^h   Chang, H ^h   Clark, C ^h   Concha, M ^h   Cornell, J ^h   Dhingra, R ^h   Doshi, A ^h   Farley, B ^h   Fermann, G ^h   Fraiz, J ^h   Fulmer, J ^h   Gaggin, H ^h   Goytia Leos, D ^h   Hahn, B ^h   Haidar, A ^h   Hamad, A ^h   Hazelrigg, M ^h   Ioachimescu, O ^h   Kabler, H ^h   Kao, C K ^h   Kazimir, M ^h   Koura, F ^h   Kung, M ^h   Lerner, R ^h   Lopez, J ^h   Macchiavelli, A ^h   Mahal, S ^h   Margolis, B ^h   McLaren, G ^h   Milling, T ^h   Mittal, M ^h   Nadar, V ^h   Ohaju, V ^h   Ortel, T ^h   Overcash, J ^h   Parthiban, K ^h   Pearl, R ^h   Pineda, L ^h   Pratt, R ^h   Pullman, J ^h   Quintana, O ^h   Rajan, R ^h   Rastogi, P ^h   Rees, C ^h   Rodriguez, W ^h   Saba, F ^h   Shammas, N ^h   Sharma, S ^h   Sokol, S ^h   Stoltz, S ^h   Tuck, M ^h   Updegrove, J ^h   Warner, A ^h   Welch, M ^h   Welker, J ^h   Whitman, B ^h   Wichman, T ^h   Yousef, K ^h   Yusen, R ^h   Zakai, N ^h   more..

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Portola Pharmaceuticals   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETRIXABAN; D DIMER; ENOXAPARIN; PLACEBO; BENZAMIDE DERIVATIVE; BLOOD CLOTTING FACTOR 10A INHIBITOR; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PYRIDINE DERIVATIVE;

ACUTE DISEASE; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; ADULT; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG ADMINISTRATION; ECHOGRAPHY; HOSPITALIZATION; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTOR; VENOUS THROMBOSIS;

ACUTE DISEASE; ADULT; AGED; BENZAMIDES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FACTOR XA INHIBITORS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; PYRIDINES; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84981709094     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1601747     Document Type: Article

References (25)

1. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 2005;94:750-9.
2. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000;160:3415-20.
3. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164:963-8.
4. Cohen AT, Spiro TE, Spyropoulos AC, et al. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. J Thromb Haemost 2014;12:479-87.
5. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med 2010;153:8-18.
6. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007;146:278-88.
7. Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800.
8. Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med 2000;161:1109-14.
9. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-9.
10. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006;332:325-9.
11. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:2 Suppl:e195S-226S.
12. Amin AN, Varker H, Princic N, Lin J, Thompson S, Johnston S. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med 2012;7:231-8.
13. Cohen AT, Spiro TE, Büller HR, et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013;368:513-23.
14. Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 2011;365:2167-77.
15. Cohen AT, Harrington R, Goldhaber SZ, et al. The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. Am Heart J 2014;167:335-41.
16. Cohen AT, Harrington R, Goldhaber SZ, et al. Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. Am Heart J 2015;169:186-7.
17. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-4.
18. The van Gogh Investigators. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 2007;357:1094-104.
19. Westfall PH, Krishen A, Young SS. Using prior information to allocate significance levels for multiple endpoints. Stat Med 1998;17:2107-19.
20. Quan H, Zhang D, Zhang J, Devlamynck L. Analysis of a binary composite endpoint with missing data in components. Stat Med 2007;26:4703-18.
21. Anderson FA Jr, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82:777-82.
22. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162:1245-8.
23. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64.
24. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71.
25. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005;93:76-9.